Concomitant use of H1 antihistamines improves survival outcomes in cancer patients on immune checkpoint inhibitor therapy: a systematic review and meta-analysis

Authors

Institutions

Publication Details

Journal
Expert Review of Anticancer Therapy
Published
2026-01-16
DOI
https://doi.org/10.1080/14737140.2026.2617952
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Concomitant use of H1 antihistamines improves survival outcomes in cancer patients on immune checkpoint inhibitor therapy: a systematic review and meta-analysis

Mário Hiroyuki Hirata, Hirata Rd, Francisco Cezar Aquino de Moraes, Rommel Mario Rodriguez Burbano et al.
Expert Review of Anticancer Therapy
Cancer Immunotherapy and Biomarkers
article

Concomitant use of H1 antihistamines improves survival outcomes in cancer patients on immune checkpoint inhibitor therapy: a systematic review and meta-analysis

Mário Hiroyuki Hirata, Hirata Rd, Francisco Cezar Aquino de Moraes, Rommel Mario Rodriguez Burbano, Pedro Henrique de Souza Wagner
article en

Abstract

No abstract available for this paper.
Expert Review of Anticancer Therapy
Universidade de São Paulo (BR), Universidade Federal de Santa Catarina (BR), Universidade Federal do Pará (BR)
Openalex Percentile: Top 86%
Cancer Immunotherapy and Biomarkers
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.